로딩 중…
지수 로딩 중…
Beta Bionics, Inc.
BBNX· NASDAQ· Health Care· Health Care Equipment & Services
$21.89+2.15%
2026-09-18
Financials
Valuation Metrics
Beta Bionics, Inc.'s Market Cap is $975M. At end of 2025 it was $1.23B. Ranked #2493 of 3,121 in US market (top 80%), #1031 of 1,463 on NASDAQ (top 70%), #156 of 205 in Health Care Equipment & Services (top 76%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $975M | US#2,493/3,121 Sec#156/205 |
| Revenue | $119M | US#2,671/3,121 Sec#179/205 |
| Net Income | $-73M | US—/3,121 Sec—/205 |
| Total Assets | $292M | US#2,919/3,121 Sec#177/205 |
| Net Assets | $256M | US#2,590/3,121 Sec#150/205 |
| Value | ||
| P/B | 3.80x | US#1,948/3,121 Sec#111/205 |
| P/S | 8.20x | US#2,604/3,121 Sec#173/205 |
| FCF Yield | -6.30% | US—/3,121 Sec—/205 |
| Profitability | ||
| ROE | -28.46% | US#2,560/3,121 Sec#156/205 |
| ROA | -24.96% | US#2,849/3,121 Sec#183/205 |
| Op. Margin | -69.75% | US#2,702/3,121 Sec#186/205 |
| Revenue Growth | 52.54% | US#213/3,121 Sec#9/205 |
| Financial Health | ||
| Debt Ratio | 14.05% | US#161/3,121 Sec#11/205 |
| Total Debt | $7M | US#2,879/3,121 Sec#192/205 |
| FCF | $-61M | US#2,552/3,121 Sec#183/205 |
| Cash | $44M | US#2,625/3,121 Sec#168/205 |
| Current Ratio | 8.88x | US#294/3,121 Sec#17/205 |
| Performance | ||
| 1Y Return | -5.03% | US#2,037/3,121 Sec#141/205 |
| 1M Return | 9.40% | US#182/3,121 Sec#27/205 |
| From 52W High | -33.08% | US#2,278/3,121 Sec#154/205 |
| 1Y MDD | -71.24% | US#2,979/3,121 Sec#189/205 |
| Trading | ||
| Volume | 1,364,103 shares | US#633/3,121 Sec#35/205 |
| Trading Value | $30M | US#1,144/3,121 Sec#82/205 |
| Per Share | ||
| EPS | $-1.64 | US—/3,121 Sec—/205 |
| BPS | $5.75 | US#2,223/3,121 Sec#139/205 |